can ghk cu make you nauseous GHK-Cu Peptide Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy GHK-Cu Peptide: Benefits for Tissue

A stall at 15 mg is a signal to reassess the overall approach, not to exceed the label

Citing significant, unresolved safety risks, a total lack of robust human clinical efficacy data, and grave concerns over immunogenicity and peptide-related impurities, the FDA officially designated 19 of the most popular therapeutic peptidesexplicitly including BPC-157, TB-500 (Thymosin beta-4 fragment), and injectable GHK-Cuas Category 2 bulk drug substances

The COA should verify peptide identity, purity (typically 98%+ for research-grade), and absence of contaminants including endotoxins, heavy metals, and residual solvents

For research only